Dr. Amanda Marie Caparso, DO

Dr. Caparso practices at Poway Surgery Center in Poway, California.

Dr. Caparso's NPI, 1003046004, was assigned on July 24, 2009. Dr. Caparso graduated from Touro University Nevada in 2009. Dr. Caparso holds California license 20A12874.

Dr. Caparso's primary practice is Poway Surgery Center, at 15611 Pomerado Rd, Poway, CA 92064. The practice phone is (858) 521-0031.

Dr. Caparso's primary practice is Poway Surgery Center in Poway, California. Dr. Caparso is also affiliated with Palomar UC San Diego Health Poway. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Caparso to 1 more hospital, 5 medical groups, 1 community health center, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caparso practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Caparso's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Caparso is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Caparso's licenses on file in 2 states: California and Ohio.

Dmand AI lists arthritis, asthma, atrial fibrillation and flutter, bipolar disorder, bursitis, chronic diabetes, chronic hypertension and chronic obstructive pulmonary disease (COPD) among the conditions Dr. Caparso treats.

CMS data shows 32 Medicare services from Dr. Caparso across 1 procedure code in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $3,495 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Caparso in 2024. The largest group is 75 to 84, with 19 patients. 73% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Caparso's median patient age at 59, with 70% women.

In 2024, Dr. Caparso wrote 3,571 Medicare Part D claims for 427 patients. 88% of them were for generic drugs. CMS names the drug for 2,886 of them, across 78 drugs with 11 or more claims each, at $260,510 in total drug cost. In 2023, CMS named 2,674 claims across 77 drugs.

Dr. Caparso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Caparso as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Caparso in 2015. Dr. Caparso's most frequent co-author is Francis A. Papay, MD.

Dmand AI links Dr. Caparso to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 49 general payments to Dr. Caparso from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $185.

Dr. Caparso graduated from Touro University Nevada in 2009.

Dr. Caparso is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.